Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing

被引:18
作者
Chadwick, Alexandra C. [1 ]
Musunuru, Kiran [1 ,2 ]
机构
[1] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA
关键词
Genome editing; Dyslipidemia; CRISPR/Cas9; PCSK9; Cardiovascular disease; INNATE IMMUNE-RESPONSE; ONE-STEP GENERATION; CRISPR-CAS9; NUCLEASES; CAS9; CELLS; SPECIFICITY; PCSK9; DNA; ADENOVIRUS; PROTEINS;
D O I
10.1007/s11883-017-0668-8
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose of Review Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated 9 (Cas9) has recently emerged as a top genome editing technology and has afforded investigators the ability to more easily study a number of diseases. This review discusses CRISPR/Cas9's advantages and limitations and highlights a few recent reports on genome editing applications for alleviating dyslipidemia through disruption of proprotein convertase subtilisin/kexin type 9 (PCSK9). Recent Findings Targeting of mouse Pcsk9 using CRISPR/Cas9 technology has yielded promising results for lowering total cholesterol levels, and several recent findings are highlighted in this review. Reported on-target mutagenesis efficiency is as high as 90% with a subsequent 40% reduction of blood cholesterol levels in mice, highlighting the potential for use as a therapeutic in human patients. Summary The ability to characterize and treat diseases is becoming easier with the recent advances in genome editing technologies. In this review, we discuss how genome editing strategies can be of use for potential therapeutic applications.
引用
收藏
页数:6
相关论文
共 52 条
[1]   A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia [J].
Cayo, Max A. ;
Mallanna, Sunil K. ;
Di Furio, Francesca ;
Jing, Ran ;
Tolliver, Lauren B. ;
Bures, Matthew ;
Urick, Amanda ;
Noto, Fallon K. ;
Pashos, Evanthia E. ;
Greseth, Matthew D. ;
Czarnecki, Maciej ;
Traktman, Paula ;
Yang, Wenli ;
Morrisey, Edward E. ;
Grompe, Markus ;
Rader, Daniel J. ;
Duncan, Stephen A. .
CELL STEM CELL, 2017, 20 (04) :478-+
[2]   Genome Editing for the Study of Cardiovascular Diseases [J].
Chadwick, Alexandra C. ;
Musunuru, Kiran .
CURRENT CARDIOLOGY REPORTS, 2017, 19 (03)
[3]   Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease [J].
Cho, Seung Woo ;
Kim, Sojung ;
Kim, Jong Min ;
Kim, Jin-Soo .
NATURE BIOTECHNOLOGY, 2013, 31 (03) :230-232
[4]   Sequence variations in PCSK9, low LDL, and protection against coronary heart disease [J].
Cohen, JC ;
Boerwinkle, E ;
Mosley, TH ;
Hobbs, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) :1264-1272
[5]   Multiplex Genome Engineering Using CRISPR/Cas Systems [J].
Cong, Le ;
Ran, F. Ann ;
Cox, David ;
Lin, Shuailiang ;
Barretto, Robert ;
Habib, Naomi ;
Hsu, Patrick D. ;
Wu, Xuebing ;
Jiang, Wenyan ;
Marraffini, Luciano A. ;
Zhang, Feng .
SCIENCE, 2013, 339 (6121) :819-823
[6]   Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing [J].
Ding, Qiurong ;
Strong, Alanna ;
Patel, Kevin M. ;
Ng, Sze-Ling ;
Gosis, Bridget S. ;
Regan, Stephanie N. ;
Cowan, Chad A. ;
Rader, Daniel J. ;
Musunuru, Kiran .
CIRCULATION RESEARCH, 2014, 115 (05) :488-+
[7]   A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models [J].
Ding, Qiurong ;
Lee, Youn-Kyoung ;
Schaefer, Esperance A. K. ;
Peters, Derek T. ;
Veres, Adrian ;
Kim, Kevin ;
Kuperwasser, Nicolas ;
Motola, Daniel L. ;
Meissner, Torsten B. ;
Hendriks, William T. ;
Trevisan, Marta ;
Gupta, Rajat M. ;
Moisan, Annie ;
Banks, Eric ;
Friesen, Max ;
Schinzel, Robert T. ;
Xia, Fang ;
Tang, Alexander ;
Xia, Yulei ;
Figueroa, Emmanuel ;
Wann, Amy ;
Ahfeldt, Tim ;
Daheron, Laurence ;
Zhang, Feng ;
Rubin, Lee L. ;
Peng, Lee F. ;
Chung, Raymond T. ;
Musunuru, Kiran ;
Cowan, Chad A. .
CELL STEM CELL, 2013, 12 (02) :238-251
[8]   Mutation of Plekha7 attenuates salt-sensitive hypertension in the rat [J].
Endres, Bradley T. ;
Priestley, Jessica R. C. ;
Palygin, Oleg ;
Flister, Michael J. ;
Hoffman, Matthew J. ;
Weinberg, Brian D. ;
Grzybowski, Michael ;
Lombard, Julian H. ;
Staruschenko, Alexander ;
Moreno, Carol ;
Jacob, Howard J. ;
Geurts, Aron M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (35) :12817-12822
[9]  
Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]
[10]   Improving CRISPR-Cas nuclease specificity using truncated guide RNAs [J].
Fu, Yanfang ;
Sander, Jeffry D. ;
Reyon, Deepak ;
Cascio, Vincent M. ;
Joung, J. Keith .
NATURE BIOTECHNOLOGY, 2014, 32 (03) :279-284